Prostate Cancer Study Group[Corporate Author] - Search Results

Year	Number of Results
2001	1
2002	2
2003	1
2004	3
2006	2
2007	3
2008	3
2009	2
2021	1
2025	0

1

Percent free prostate specific antigen does not enhance the specificity of total prostate specific antigen for the detection of prostate cancer in Korean men 50 to 65 years old: a prospective multicenter study.

Jeong IG, Lee KH; Korean Urological Oncologic Society Prostate Cancer Study Group. Jeong IG, et al. J Urol. 2008 Jan;179(1):111-6. doi: 10.1016/j.juro.2007.08.153. Epub 2007 Nov 13. J Urol. 2008. PMID: 17997422

2

Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis.

Collin SM, Metcalfe C, Zuccolo L, Lewis SJ, Chen L, Cox A, Davis M, Lane JA, Donovan J, Smith GD, Neal DE, Hamdy FC, Gudmundsson J, Sulem P, Rafnar T, Benediktsdottir KR, Eeles RA, Guy M, Kote-Jarai Z; UK Genetic Prostate Cancer Study Group; Morrison J, Al Olama AA, Stefansson K, Easton DF, Martin RM. Collin SM, et al. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2528-39. doi: 10.1158/1055-9965.EPI-09-0223. Epub 2009 Aug 25. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19706844 Free article.

3

A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer.

Hoshi S, Yamaguchi O, Fujioka T, Arai Y, Tomita Y, Habuchi T, Ohyama C, Suzuki T, Orikasa S; Tohoku Prostate Cancer Study Group. Hoshi S, et al. Int J Clin Oncol. 2006 Aug;11(4):303-8. doi: 10.1007/s10147-006-0563-8. Int J Clin Oncol. 2006. PMID: 16937304 Clinical Trial.

4

A prospective and randomized study of primary hormonal therapy for patients with localized or locally advanced prostate cancer unsuitable for radical prostatectomy: results of the 5-year follow-up.

Akaza H, Homma Y, Okada K, Yokoyama M, Usami M, Hirao Y, Tsushima T, Ohashi Y, Aso Y; Prostate Cancer Study Group. Akaza H, et al. BJU Int. 2003 Jan;91(1):33-6. doi: 10.1046/j.1464-410x.2003.04014.x. BJU Int. 2003. PMID: 12614246 Clinical Trial.

5

Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study.

Seo HK, Chung MK, Ryu SB, Lee KH; Korean Urological Oncologic Society Prostate Cancer Study Group. Seo HK, et al. Urology. 2007 Dec;70(6):1109-12. doi: 10.1016/j.urology.2007.07.052. Urology. 2007. PMID: 18158028

6

Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: Comparing between high- and middle-income Asian countries.

Lim J, Onozawa M, Saad M, Ong TA; A-CaP (Asian Prostate Cancer) Study; J-CaP (Japan Prostate Cancer Study Group); M-CaP (Malaysia Prostate Cancer Study Group); Malek R, Akaza H. Lim J, et al. Cancer Sci. 2021 Jun;112(6):2071-2080. doi: 10.1111/cas.14889. Epub 2021 May 3. Cancer Sci. 2021. PMID: 33738901 Free PMC article. Review.

7

Endocrine therapy with or without radical prostatectomy for T1b-T3N0M0 prostate cancer.

Homma Y, Akaza H, Okada K, Yokoyama M, Usami M, Hirao Y, Tsushima T, Sakamoto A, Ohashi Y, Aso Y; Prostate Cancer Study Group. Homma Y, et al. Int J Urol. 2004 Apr;11(4):218-24. doi: 10.1111/j.1442-2042.2003.00781.x. Int J Urol. 2004. PMID: 15028100 Free article. Clinical Trial.

8

Efficacy of primary hormone therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up.

Akaza H, Homma Y, Usami M, Hirao Y, Tsushima T, Okada K, Yokoyama M, Ohashi Y, Aso Y; Prostate Cancer Study Group. Akaza H, et al. BJU Int. 2006 Sep;98(3):573-9. doi: 10.1111/j.1464-410X.2006.06349.x. BJU Int. 2006. PMID: 16925756 Clinical Trial.

9

Denosumab in men receiving androgen-deprivation therapy for prostate cancer.

Smith MR, Egerdie B, Hernández Toriz N, Feldman R, Tammela TL, Saad F, Heracek J, Szwedowski M, Ke C, Kupic A, Leder BZ, Goessl C; Denosumab HALT Prostate Cancer Study Group. Smith MR, et al. N Engl J Med. 2009 Aug 20;361(8):745-55. doi: 10.1056/NEJMoa0809003. Epub 2009 Aug 11. N Engl J Med. 2009. PMID: 19671656 Free PMC article. Clinical Trial.

10

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.

Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Zheng M; Zoledronic Acid Prostate Cancer Study Group. Saad F, et al. J Natl Cancer Inst. 2004 Jun 2;96(11):879-82. doi: 10.1093/jnci/djh141. J Natl Cancer Inst. 2004. PMID: 15173273 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year